Literature DB >> 23918988

Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-γ+CD4+ T cell numbers during colitis development in mice.

Damian Maseda1, Kathleen M Candando1, Susan H Smith1, Ioannis Kalampokis1, Casey T Weaver2, Scott E Plevy3, Jonathan C Poe1, Thomas F Tedder1.   

Abstract

The spleen regulatory B cell subset with the functional capacity to express IL-10 (B10 cells) modulates both immune responses and autoimmune disease severity. However, the peritoneal cavity also contains relatively high frequencies of functionally defined IL-10-competent B10 cells. In this study, peritoneal cavity B10 cells shared similar cell surface phenotypes with their spleen counterparts. However, peritoneal cavity B10 cells were 10-fold more frequent among B cells than occurred within the spleen, intestinal tract, or mesenteric lymph nodes and were present at higher proportions among the phenotypically defined peritoneal B1a > B1b > B2 cell subpopulations. The development or localization of B10 cells within the peritoneal cavity was not dependent on the presence of commensal microbiota, T cells, IL-10 or B10 cell IL-10 production, or differences between their fetal liver or adult bone marrow progenitor cell origins. The BCR repertoire of peritoneal cavity B10 cells was diverse, as occurs in the spleen, and predominantly included germline-encoded VH and VL regions commonly found in either the conventional or B1 B cell compartments. Thereby, the capacity to produce IL-10 appears to be an intrinsic functional property acquired by clonally diverse B cells. Importantly, IL-10 production by peritoneal cavity B cells significantly reduced disease severity in spontaneous and induced models of colitis by regulating neutrophil infiltration, colitogenic CD4(+) T cell activation, and proinflammatory cytokine production during colitis onset. Thus, the numerically small B10 cell subset within the peritoneal cavity has regulatory function and is important for maintaining homeostasis within gastrointestinal tissues and the immune system.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23918988      PMCID: PMC3770313          DOI: 10.4049/jimmunol.1300649

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  72 in total

1.  Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice.

Authors:  Mayuka Horikawa; Veronique Minard-Colin; Takashi Matsushita; Thomas F Tedder
Journal:  J Clin Invest       Date:  2011-10-24       Impact factor: 14.808

2.  Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice.

Authors:  Qing Ding; Melissa Yeung; Geoffrey Camirand; Qiang Zeng; Hisaya Akiba; Hideo Yagita; Geetha Chalasani; Mohamed H Sayegh; Nader Najafian; David M Rothstein
Journal:  J Clin Invest       Date:  2011-08-08       Impact factor: 14.808

3.  B cells exposed to enterobacterial components suppress development of experimental colitis.

Authors:  Esben Gjerløff Wedebye Schmidt; Hjalte List Larsen; Nanna Ny Kristensen; Steen Seier Poulsen; Mogens Helweg Claesson; Anders Elm Pedersen
Journal:  Inflamm Bowel Dis       Date:  2011-05-25       Impact factor: 5.325

Review 4.  Novel regulatory functions for Toll-like receptor-activated B cells during intracellular bacterial infection.

Authors:  Simon Fillatreau
Journal:  Immunol Rev       Date:  2011-03       Impact factor: 12.988

5.  B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice.

Authors:  Patrizia Scapini; Chrystelle Lamagna; Yongmei Hu; Karim Lee; Qizhi Tang; Anthony L DeFranco; Clifford A Lowell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-12       Impact factor: 11.205

6.  Regulatory role of mature B cells in a murine model of inflammatory bowel disease.

Authors:  E Mizoguchi; A Mizoguchi; F I Preffer; A K Bhan
Journal:  Int Immunol       Date:  2000-05       Impact factor: 4.823

7.  The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production.

Authors:  Masanori Matsumoto; Yoko Fujii; Akemi Baba; Masaki Hikida; Tomohiro Kurosaki; Yoshihiro Baba
Journal:  Immunity       Date:  2011-04-28       Impact factor: 31.745

8.  Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis.

Authors:  Keith Leiper; Kate Martin; Anthony Ellis; Sreedhar Subramanian; Alastair J Watson; Steve E Christmas; Deborah Howarth; Fiona Campbell; Jonathan M Rhodes
Journal:  Gut       Date:  2011-04-06       Impact factor: 23.059

9.  Prostaglandin E2 and SOCS1 have a role in intestinal immune tolerance.

Authors:  Takatoshi Chinen; Kyoko Komai; Go Muto; Rimpei Morita; Naoko Inoue; Hideyuki Yoshida; Takashi Sekiya; Ryoko Yoshida; Kazuhiko Nakamura; Ryoichi Takayanagi; Akihiko Yoshimura
Journal:  Nat Commun       Date:  2011-02-08       Impact factor: 14.919

10.  Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice.

Authors:  Jonathan C Poe; Susan H Smith; Karen M Haas; Koichi Yanaba; Takeshi Tsubata; Takashi Matsushita; Thomas F Tedder
Journal:  PLoS One       Date:  2011-07-25       Impact factor: 3.240

View more
  69 in total

Review 1.  The role of B-1 cells in inflammation.

Authors:  Monowar Aziz; Nichol E Holodick; Thomas L Rothstein; Ping Wang
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

Review 2.  Therapeutic Potential of B-1a Cells in COVID-19.

Authors:  Monowar Aziz; Max Brenner; Ping Wang
Journal:  Shock       Date:  2020-11       Impact factor: 3.454

Review 3.  The role of regulatory B cells in digestive system diseases.

Authors:  Zhenyu Zhou; Lei Gong; Xiaoyun Wang; Zhen Hu; Gaojue Wu; Xuejun Tang; Xiaobin Peng; Shuan Tang; Miao Meng; Hui Feng
Journal:  Inflamm Res       Date:  2016-11-22       Impact factor: 4.575

Review 4.  Antibody-independent functions of B cells: a focus on cytokines.

Authors:  Ping Shen; Simon Fillatreau
Journal:  Nat Rev Immunol       Date:  2015-06-12       Impact factor: 53.106

Review 5.  Skin-Associated B Cells in Health and Inflammation.

Authors:  Gudrun F Debes; Shannon E McGettigan
Journal:  J Immunol       Date:  2019-03-15       Impact factor: 5.422

6.  Suppression of autoimmunity by CD5(+) IL-10-producing B cells in lupus-prone mice.

Authors:  Y Baglaenko; K P Manion; N-H Chang; C Loh; G Lajoie; J E Wither
Journal:  Genes Immun       Date:  2015-05-14       Impact factor: 2.676

Review 7.  B cells responses and cytokine production are regulated by their immune microenvironment.

Authors:  Monica I Vazquez; Jovani Catalan-Dibene; Albert Zlotnik
Journal:  Cytokine       Date:  2015-03-02       Impact factor: 3.861

8.  Amyloid fibrils activate B-1a lymphocytes to ameliorate inflammatory brain disease.

Authors:  Michael Phillip Kurnellas; Eliver Eid Bou Ghosn; Jill M Schartner; Jeanette Baker; Jesse J Rothbard; Robert S Negrin; Leonore A Herzenberg; C Garrison Fathman; Lawrence Steinman; Jonathan B Rothbard
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-30       Impact factor: 11.205

Review 9.  Transplantation tolerance: don't forget about the B cells.

Authors:  A S Chong; S H Khiew
Journal:  Clin Exp Immunol       Date:  2017-02-28       Impact factor: 4.330

Review 10.  Regulatory B10 cell development and function.

Authors:  Jacquelyn M Lykken; Kathleen M Candando; Thomas F Tedder
Journal:  Int Immunol       Date:  2015-08-06       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.